Cover Image
市場調查報告書

Monosol Rx, LLC:產品平台分析

Monosol Rx, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293916
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Monosol Rx, LLC:產品平台分析 Monosol Rx, LLC - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 28 Pages
簡介

Monosol Rx, LLC 為致力於薄膜型醫藥品和成藥開發與商品化的製藥公司,也提供營養補充品,及各種一般消費品和包裝材料,偏頭痛及噁心治療藥。該公司還提供患者、醫生、看護人取向微創的治療方法,涵蓋從臨床前階段到後期階段範圍的醫藥品。

本報告提供Monosol Rx, LLC 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的/作用機製/給藥途徑/分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Monosol Rx, LLC的基本資料

  • Monosol Rx, LLC概要
  • 主要資訊
  • 企業資料

Monosol Rx, LLC:R&D概要

  • 主要的治療範圍

Monosol Rx, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Monosol Rx, LLC:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 被申請的產品/聯合治療模式
    • 在前臨床階段的產品/聯合治療模式

Monosol Rx, LLC:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Monosol Rx, LLC:藥物簡介

  • testosterone
  • sildenafil citrate
  • tadalafil
  • epinephrine
  • rizatriptan benzoate

Monosol Rx, LLC:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Monosol Rx, LLC:暫停中的計劃

Monosol Rx, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07488CDB

Summary

Global Markets Direct's, 'Monosol Rx, LLC - Product Pipeline Review - 2015', provides an overview of the Monosol Rx, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Monosol Rx, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Monosol Rx, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Monosol Rx, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Monosol Rx, LLC's pipeline products

Reasons to buy

  • Evaluate Monosol Rx, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Monosol Rx, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Monosol Rx, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Monosol Rx, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Monosol Rx, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Monosol Rx, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Monosol Rx, LLC Snapshot
    • Monosol Rx, LLC Overview
    • Key Information
    • Key Facts
  • Monosol Rx, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Monosol Rx, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Monosol Rx, LLC - Pipeline Products Glance
    • Monosol Rx, LLC - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Monosol Rx, LLC - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
    • Monosol Rx, LLC - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Monosol Rx, LLC - Drug Profiles
    • testosterone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • sildenafil citrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tadalafil
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • epinephrine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • rizatriptan benzoate
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Monosol Rx, LLC - Pipeline Analysis
  • Monosol Rx, LLC - Pipeline Products by Target
  • Monosol Rx, LLC - Pipeline Products by Route of Administration
  • Monosol Rx, LLC - Pipeline Products by Molecule Type
  • Monosol Rx, LLC - Pipeline Products by Mechanism of Action
  • Monosol Rx, LLC - Dormant Projects
  • Monosol Rx, LLC - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Monosol Rx, LLC, Key Information
  • Monosol Rx, LLC, Key Facts
  • Monosol Rx, LLC - Pipeline by Indication, 2015
  • Monosol Rx, LLC - Pipeline by Stage of Development, 2015
  • Monosol Rx, LLC - Monotherapy Products in Pipeline, 2015
  • Monosol Rx, LLC - Partnered Products in Pipeline, 2015
  • Monosol Rx, LLC - Partnered Products/ Combination Treatment Modalities, 2015
  • Monosol Rx, LLC - Phase I, 2015
  • Monosol Rx, LLC - IND/CTA Filed, 2015
  • Monosol Rx, LLC - Preclinical, 2015
  • Monosol Rx, LLC - Unknown, 2015
  • Monosol Rx, LLC - Pipeline by Target, 2015
  • Monosol Rx, LLC - Pipeline by Route of Administration, 2015
  • Monosol Rx, LLC - Pipeline by Molecule Type, 2015
  • Monosol Rx, LLC - Pipeline Products by Mechanism of Action, 2015
  • Monosol Rx, LLC - Dormant Developmental Projects,2015
  • Monosol Rx, LLC, Other Locations

List of Figures

  • Monosol Rx, LLC - Pipeline by Top 10 Indication, 2015
  • Monosol Rx, LLC - Pipeline by Stage of Development, 2015
  • Monosol Rx, LLC - Monotherapy Products in Pipeline, 2015
  • Monosol Rx, LLC - Pipeline by Top 10 Target, 2015
  • Monosol Rx, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Monosol Rx, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top